Assessment of mammographic density before and after first full-term pregnancy

European Journal of Cancer Prevention

Volumn 19, Issue 6, 2010, Pages 405-412

  Loehberg, Christian R ^a   Heusinger, Katharina ^a   Jud, Sebastian M ^a   Haeberle, Lothar ^a   Hein, Alexander ^a   Rauh, Claudia ^a   Bani, Mayada R ^a   Lux, Michael P ^a   Schrauder, Michael G ^a   Bayer, Christian M ^a   Helbig, Cosima ^c   Grolik, Ronald ^c   Adamietz, Boris ^b   Schulz Wendtland, Ruediger ^b   Beckmann, Matthias W ^a   Fasching, Peter A ^a,d  

^a University Breast Center Franconia   (Germany)

^b Institute for Diagnostic Radiology   (Germany)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast cancer risk; mammographic density; pregnancy

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CASE REPORT; CONTROLLED STUDY; FEMALE; HUMAN; MAMMOGRAPHIC DENSITY; MAMMOGRAPHY; ONCOLOGICAL PARAMETERS; PREMENOPAUSE; PRIMIGRAVIDA; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS;

ADULT; BREAST; FEMALE; HUMANS; LONGITUDINAL STUDIES; MAMMOGRAPHY; PARITY; PREGNANCY; RISK FACTORS; TERM BIRTH; TIME FACTORS;

EID: 77958172712     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e32833ca1f4     Document Type: Article

References (62)

1. American College of Radiology (1993). Breast imaging reporting and data system (BI-RADS). Reston, VA: American College of Radiology.
2. American College of Radiology, BI-RADS Committee (2003). ACR BI-RADS breast imaging and reporting data system: breast imaging atlas. 4th ed. Reston, VA: American College of Radiology.
3. Andrieu N, Easton DF, Chang-Claude J, Rookus MA, Brohet R, Cardis E, et al. (2006a). Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators' Group. J Clin Oncol 24:3361-3366.
4. Andrieu N, Goldgar DE, Easton DF, Rookus M, Brohet R, Antoniou AC, et al. (2006b). Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS). J Natl Cancer Inst 98:535-544.
5. Atkinson C,Warren R, Bingham SA, Day NE (1999). Mammographic patterns as a predictive biomarker of breast cancer risk: effect of tamoxifen. Cancer Epidemiol Biomarkers Prev 8:863-866.
6. Band PR, Le ND, Fang R, Deschamps M (2002). Carcinogenic and endocrine disrupting effects of cigarette smoke and risk of breast cancer. Lancet 360:1044-1049.
7. Bartow SA, Pathak DR, Mettler FA, Key CR, Pike MC (1995). Breast mammographic pattern: a concatenation of confounding and breast cancer risk factors. Am J Epidemiol 142:813-819.
8. BergWA, Campassi C, Langenberg P, Sexton MJ (2000). Breast imaging reporting and data system: inter-observer and intra-observer variability in feature analysis and final assessment. AJR Am J Roentgenol 174:1769-1777.
9. Bergkvist L, Tabà r L, Bergström R, Adami HO (1987). Epidemiologic determinants of the mammographic parenchymal pattern. A populationbased study within a mammographic screening program. Am J Epidemiol 126:1075-1081.
10. Bland JM, Altman DG (1986). Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1:307-310.
11. Boyd NF, Lockwood GA, Martin LJ, Knight JA, Jong RA, Fishell E, et al. (1999). Mammographic densities and risk of breast cancer among subjects with a family history of this disease. J Natl Cancer Inst 91:1404-1408.
12. Boyd NF, Jensen HM, Cooke G, Han HL, Lockwood GA, Miller AB (2000). Mammographic densities and the prevalence and incidence of histological types of benign breast disease. Reference Pathologists of the Canadian National Breast Screening Study. Eur J Cancer Prev 9:15-24.
13. Boyd N, Martin L, Stone J, Little L, Minkin S, Yaffe M (2002). A longitudinal study of the effects of menopause on mammographic features. Cancer Epidemiol Biomarkers Prev 11:1048-1053.
14. Boyd NF, Rommens JM, Vogt K, Lee V, Hopper JL, Yaffe MJ, Paterson AD (2006a). Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol 6:798-808.
15. Boyd NF, Martin LJ, Sun L, Guo H, Chiarelli A, Hislop G, et al. (2006b). Body size, mammographic density, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 15:2086-2092.
16. Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, et al. (2007). Mammographic density and the risk and detection of breast cancer. N Engl J Med 356:227-236.
17. Brisson J, Sadowsky NL, Twaddle JA, Morrison AS, Cole P, Merletti F (1982). The relation of mammographic features of the breast to breast cancer risk factors. Am J Epidemiol 115:438-443.
18. Brisson J, Brisson B, Coté G, Maunsell E, Bérubé S, Robert J (2000). Tamoxifen and mammographic breast densities. Cancer Epidemiol Biomarkers Prev 9:911-915.
19. Byrne C, Schairer C, Wolfe J, Parekh N, Salane M, Brinton LA, et al. (1995). Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst 87:1622-1629.
20. Byrne C, Schairer C, Brinton LA, Wolfe J, Parekh N, Salane M, et al. (2001). Effects of mammographic density and benign breast disease on breast cancer risk (United States). Cancer Causes Control 12:103-110.
21. Chang-Claude J, Eby N, Kiechle M, Bastert G, Becher H (2000). Breastfeeding and breast cancer risk by age 50 among women in Germany. Cancer Causes Control 11:687-695.
22. Collaborative Group on Hormonal Factors in Breast Cancer (2002). Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50 302 women with breast cancer and 96 973 women without the disease. Lancet 360:187-195.
23. Cuzick J, Warwick J, Pinney E, Warren RM, Duffy SW (2004). Tamoxifen and breast density in women at increased risk of breast cancer. J Natl Cancer Inst 96:621-628.
24. D'Cruz CM, Moody SE, Master SR, Hartman JL, Keiper EA, Imielinski MB, et al. (2002). Persistent parity-induced changes in growth factors, TGFbeta3, and differentiation in the rodent mammary gland. Mol Endocrinol 16:2034-2051.
25. De Waard F, Rombach JJ, Collette HJ, Slotboom B (1984). Breast cancer risk associated with reproductive factors and breast parenchymal patterns. J Natl Cancer Inst 72:1277-1282.
26. Ernster VL, Sacks ST, Peterson CA, Schweitzer RJ (1980). Mammographic parenchymal patterns and risk factors for breast cancer. Radiology 134:617-620.
27. Ginger MR, Rosen JM (2003). Pregnancy-induced changes in cell-fate in the mammary gland. Breast Cancer Res 5:192-197.
28. Gram IT, Funkhouser E, Tabar L (1995). Reproductive and menstrual factors in relation to mammographic parenchymal patterns among perimenopausal women. Br J Cancer 71:647-650.
29. Greendale GA, Reboussin BA, Slone S, Wasilauskas C, Pike MC, Ursin G (2003). Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst 95:30-37.
30. Grove JS, Goodman MJ, Gilbert F, Clyde D (1979). Factors associated with breast structure in breast cancer patients. Cancer 43:1895-1899.
31. Grove JS, Goodman MJ, Gilbert FI Jr, Mi MP (1985). Factors associated with mammographic pattern. Br J Radiol 58:21-25.
32. Häberle L, Pfahlberg A, Gefeller O (2009). Assessment of multiple ordinal endpoints. Biom J 51:217-226.
33. Hainline S, Myers L, McLelland R, Newell J, Grufferman S, Shingleton W (1978). Mammographic patterns and risk of breast cancer. AJR Am J Roentgenol 130:1157-1158.
34. Harvey JA, Bovbjerg VE (2004). Quantitative assessment of mammographic breast density: relationship with breast cancer risk. Radiology 230:29-41.
35. Helmrich SP, Shapiro S, Rosenberg L, Kaufman DW, Slone D, Bain C, et al. (1983). Risk factors for breast cancer. Am J Epidemiol 117:35-45.
36. Kaufman Z, Garstin WI, Hayes R, Michell MJ, Baum M (1991). The mammographic parenchymal patterns of nulliparous women and women with a family history of breast cancer. Clin Radiol 43:385-388.
37. Kerlikowske K, Ichikawa L, Miglioretti DL, Buist DS, Vacek PM, Smith-Bindman R, et al. (2007). National Institutes of Health Breast Cancer Surveillance Consortium: longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk. J Natl Cancer Inst 99:386-395.
38. Lam PB, Vacek PM, Geller BM, Muss HB (2000). The association of increased weight, body mass index, and tissue density with the risk of breast carcinoma in Vermont. Cancer 89:369-375.
39. Lord SJ, Bernstein L, Johnson KA, Malone KE, McDonald JA, Marchbanks PA, et al. (2008). Breast cancer risk and hormone receptor status in older women by parity, age of first birth, and breastfeeding: a case-control study. Cancer Epidemiol Biomarkers Prev 17:1723-1730.
40. MacMahon B, Cole P, Lin TM (1970). Age at first birth and breast cancer risk. Bull World Health Organ 43:209-221.
41. Maskarinec G, Pagano I, Lurie G, Kolonel LN (2006). A longitudinal investigation of mammographic density: the multiethnic cohort. Cancer Epidemiol Biomarkers Prev 15:732-739.
42. McCormack VA, dos Santos Silva I (2006). Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15:1159-1169.
43. Rosenbaum PR (1994). Coherence in observational studies. Biometrics 50: 368-374.
44. Russo IH, Russo J (1978). Developmental stage of the rat mammary gland as determinant of its susceptibility to 7,12-dimethylbenz[a]anthracene. J Natl Cancer Inst 61:1439-1449.
45. Russo J, Russo IH (1997). Toward a unified concept of mammary carcinogenesis. Prog Clin Biol Res 396:1-16.
46. Russo J, Tay LK, Russo IH (1982). Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res Treat 2:5-73.
47. Russo J, Tait L, Russo IH (1983). Susceptibility of the mammary gland to carcinogenesis. III. The cell of origin of rat mammary carcinoma. Am J Pathol 113:50-66.
48. Russo J, Ao X, Grill C, Russo IH (1999). Pattern of distribution of cells positive for estrogen receptor alpha and progesterone receptor in relation to proliferating cells in the mammary gland. Breast Cancer Res Treat 53:217-227.
49. Russo J, Balogh GA, Chen J (2006). The concept of stem cell in the mammary gland and its implication in morphogenesis, cancer and prevention. Front Biosci 11:151-172.
50. Russo J, Balogh GA, Russo IH (2008). Full-term pregnancy induces a specific genomic signature in the human breast. Cancer Epidemiol Biomarkers Prev 17:51-66.
51. Rutter CM, Mandelson MT, Laya MB, Seger DJ, Taplin S (2001). Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. JAMA 285:171-176.
52. Sivaraman L, Conneely OM, Medina D, O'Malley BW (2001). p53 is a potential mediator of pregnancy and hormone-induced resistance to mammary carcinogenesis. Proc Natl Acad Sci USA 98:12379-12384.
53. Stone J, Warren RM, Pinney E, Warwick J, Cuzick J (2009). Determinants of percentage and area measures of mammographic density. Am J Epidemiol 170:1571-1578.
54. Stuedal A, Ma H, Bjørndal H, Ursin G (2009). Postmenopausal hormone therapy with estradiol and norethisterone acetate and mammographic density: findings from a cross-sectional study among Norwegian women. Climacteric 12:248-258.
55. Ursin G, Astrahan MA, Salane M, Parisky YR, Pearce JG, Daniels JR, et al. (1998). The detection of changes in mammographic densities. Cancer Epidemiol Biomarkers Prev 7:43-47.
56. Ursin G, Ma H, Wu AH, Bernstein L, Salane M, Parisky YR, et al. (2003). Mammographic density and breast cancer in three ethnic groups. Cancer Epidemiol Biomarkers Prev 12:332-338.
57. Vachon CM, Kuni CC, Anderson K, Anderson VE, Sellers TA (2000). Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States). Cancer Causes Control 11:653-662.
58. Vachon CM, van Gils CH, Sellers TA, Ghosh K, Pruthi S, Brandt KR, Pankratz VS (2007). Mammographic density, breast cancer risk and risk prediction. Breast Cancer Res 9:217.
59. Warren R (2004). Hormones and mammographic breast density. Maturitas 49:67-78.
60. Whitehead J, Carlile T, Kopecky KJ, Thompson DJ, Gilbert FI Jr, Present AJ, et al. (1985). The relationship between Wolfe's classification of mammograms, accepted breast cancer risk factors, and the incidence of breast cancer. Am J Epidemiol 122:994-1006.
61. Wolfe JN, Saftlas AF, Salane M (1987). Mammographic parenchymal patterns and quantitative evaluation of mammographic densities: a case-control study. AJR Am J Roentgenol 148:1087-1092.
62. Yaffe MJ (2008). Mammographic density. Measurement of mammographic density. Breast Cancer Res 10:209.